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Abstract
Dysregulation of intracellular Ca
2+ homeostasis may underlie amyloid b peptide (Ab) toxicity in Alzheimer’s Disease (AD) but
the mechanism is unknown. In search for this mechanism we found that Ab1–42 oligomers, the assembly state correlating
best with cognitive decline in AD, but not Ab fibrils, induce a massive entry of Ca
2+ in neurons and promote mitochondrial
Ca
2+ overload as shown by bioluminescence imaging of targeted aequorin in individual neurons. Ab oligomers induce also
mitochondrial permeability transition, cytochrome c release, apoptosis and cell death. Mitochondrial depolarization
prevents mitochondrial Ca
2+ overload, cytochrome c release and cell death. In addition, we found that a series of non-
steroidal anti-inflammatory drugs (NSAIDs) including salicylate, sulindac sulfide, indomethacin, ibuprofen and R-flurbiprofen
depolarize mitochondria and inhibit mitochondrial Ca
2+ overload, cytochrome c release and cell death induced by Ab
oligomers. Our results indicate that i) mitochondrial Ca
2+ overload underlies the neurotoxicity induced by Ab oligomers and
ii) inhibition of mitochondrial Ca
2+ overload provides a novel mechanism of neuroprotection by NSAIDs against Ab
oligomers and AD.
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Introduction
Alzheimer’s Disease (AD) is a devastating neurodegenerative
disorder due to a massive neuron dysfunction and loss related to
development of senile plaques that are made of amyloid b peptide
(Ab), a cleavage product of the amyloid precursor protein. Early
affected areas in the brain are the cortex and hippocampus.
However, neuropathological studies show frequent and varied
cerebellar changes in the late stages of the disease [1]. In fact, the
cerebellum has been shown to be a unique organ in terms of AD
manifestations because it is virtually free of neurofibrillary
pathology but there is an strong correlation between cerebellar
atrophy -with large cell death in the granular layer- and duration
and stage of AD [1]. Although many in vitro studies have been
carried out using cortical and hippocampal neurons, cerebellar
granule cells have been also used for studies of Ab neurotoxicity
[2–4]. Several mechanisms have been envisioned. First, the
‘‘inflammatory hypothesis’’ proposes that Ab may promote a
damaging inflammation reaction. This view is supported among
other evidence by the neuroprotection afforded by NSAIDs [5].
Second, Ab promotes mitochondrial dysfunction and apoptosis
and this toxicity contributes to AD [6] but the mechanism is
unclear. Ab may associate with mitochondrial membranes in
mutant mice and patients with AD and mitochondria from mutant
mice show lower levels of oxygen consumption and reduced
respiratory complex-associated enzymatic activity suggesting that
mitochondria-bound Ab may impact on mitochondrial activity [7–
9]. Finally, AD has been also related to a general dyshomeostasis
of intracellular Ca
2+, a key second messenger involved in multiple
neuronal functions. This view is supported by reports on
dysregulation of intracellular Ca
2+ promoted by Ab and mutant
presenilins [10]. Ab may promote Ca
2+ entry into neurons but
results are controversial [11,12]. Part of the controversy may relate
to the fact that Ab toxicity depends on its assembly state that varies
from monomers to small, soluble oligomers and fibrils [13]. Small
assemblies (oligomers) of unmodified Ab are becoming the
proximate neurotoxin in AD [13,14], but most studies used fibrils.
Intracellular Ca
2+ levels are important for AD since overexpres-
sion of calbindin28k, an endogenous Ca
2+ buffer, prevents neuron
death in AD models [15]. However the link between putative
changes in intracellular Ca
2+ and cell damage is unknown. A rise
in mitochondrial Ca
2+ concentration ([Ca
2+]mit) might contribute
to neurotoxicity but monitoring [Ca
2+]mit in individual neurons
has been challenging. We have addressed the effects of Ab
assembly state on Ca
2+ influx and mitochondrial Ca
2+ uptake
using photon counting imaging of neurons expressing targeted
aequorin [16]. We found that only oligomers, but not fibrils,
increased cytosolic and mitochondrial Ca
2+ concentrations.
Accordingly we asked for the role of mitochondrial Ca
2+ uptake
on neurotoxicity induced by Ab oligomers. Finally, we tested
PLoS ONE | www.plosone.org 1 July 2008 | Volume 3 | Issue 7 | e2718whether NSAIDs may protect against Ab toxicity acting on
subcellular Ca
2+ fluxes. For these studies we have used mainly
cerebellar granule cells although some experiments have been also
carried out in cortical and hippocampal neurons.
Results
Ab oligomers but not fibrils induce entry of Ca
2+ into
neurons
We have used the protocol reported by Klein [17] to prepare
oligomers and fibrils from Ab1–42 obtained from a commercial
source (Bachem). Since the standard protocol of preparation
includes a precipitation step in which some protein sample is lost,
we hydrolyzed an aliquot of the final solution of both oligomers
and fibrils in order to carry out an amino acid analysis. This
procedure allowed us to obtain the real concentration of these
compounds in solution. In the second place we characterized the
quaternary structure (dimers, trimers, tetramers, etc.) of both the
oligomers and fibrils using non-denaturing SDS-PAGE (pseudo-
native gels). We were unable to stain the Aß1–42 peptides using
Coomassie blue even when 2 mg of peptide were loaded per lane
(data not shown). However, using silver staining we were able to
determine the presence of high-molecular mass species in the SDS-
PAGE. We rationalized that despite the fact that the samples were
not boiled, a significant population of protein-protein interactions
might be lost in the presence of SDS. However, were able to
clearly identify monomers, dimers and tetramers in our prepara-
tion of oligomers (Figure S1A). This migration pattern of Aß1–42
oligomers in SDS-PAGE gels is well characterized [18]. When the
preparation of fibrils was analyzed by SDS-GEL and silver
staining, we could unambiguously identify the presence of
monomers, dimers, trimers, tetramers and some larger oligomer-
ization species in the gel. In addition, a certain amount of large
molecular weight fibrils appeared at the top, incapable of entering
the separating gel (Figure S1B). Similar results were obtained
when the gel was transferred to a nitrocellulose membrane and the
distribution of high-molecular mass species was determined by
Western-blot using a monoclonal antibody raised against Aß1–42
(data not shown). In the third place, electron microscopy was used
in order to characterize our Aß1–42 fibrils. Negative staining using
uranyl acetate undoubtedly showed the presence of large fibrils in
solution (Figure S1C). Most of these fibrils were similar in width
and with a length that usually varied between 200 and 800 nm.
Once Ab preparations were characterized, we studied the effects
of oligomer and fibril preparations on [Ca
2+]cyt. As a positive
control, we used also the toxic fragment Ab25–35 at large
concentrations (20 mM) that have been shown previously to be
neurotoxic and produce large increases in [Ca
2+]cyt in several
neuron models including GT1 neural cells [19]. The effects of
Ab1–42 oligomers, Ab1–42 fibrils and the toxic fragment Ab25–35 (a
surrogate of Ab) on cytosolic Ca
2+ concentration ([Ca
2+]cyt) were
tested by fluorescence microscopy (Fig. 1). We find that Ab25–35
increases [Ca
2+]cyt in both GT1 neural cells (Fig. 1A) and
cerebellar granule cells (Fig. 1B). In both cell types, increases in
[Ca
2+]cyt are heterogeneous and show different lags and kinetics.
In about two thirds of the cells, [Ca
2+]cyt remain increased even
after washout of the peptide. The increase in [Ca
2+]cyt induced by
Ab25–35 is abolished in medium lacking extracellular Ca
2+ and the
responses resume after restoring extracellular Ca
2+ (Fig. 1C)
suggesting that Ab25–35 promotes entry of Ca
2+ rather than release
from intracellular Ca
2+ stores. Cerebellar granule cells responded
also to high K
+ medium (K) after Ab25–35 (Fig. 1C). Next we tested
the effects of Ab1–42 in its different assembly states (fibrils and
oligomers) prepared from synthetic Ab1–42 [17,20] in cerebellar
granule cells. It has been reported that Ab1–42 fibrils are less toxic
than Ab1–42 oligomers but produce the same toxicity when used at
larger concentrations [13]. For example, at concentrations of
about 5 mM, Ab1–42 fibrils are equally toxic than Ab1–42 oligomers
at concentrations ranking 100 nM–1 mM. We found that, at 500
nM, Ab1–42 fibrils induce no [Ca
2+]cyt increase (data not shown).
At 2 mM, Ab1–42 fibrils induce little or no [Ca
2+]cyt rise despite
that Ab25–35 increases [Ca
2+]cyt in the same neurons and cells
responded also to N-methyl D-aspartate (NMDA) and K
+
(Fig. 1D). In contrast to fibrils, Ab1–42 oligomers, at 500 nM,
induce a large and sustained increase in [Ca
2+]cyt in most cells
(Fig. 1E). The increases in [Ca
2+]cyt induced by Ab1–42 oligomers
are heterogeneous showing different lags and kinetics and often
[Ca
2+]cyt remain increased after washout of the peptide. The
increase in [Ca
2+]cyt induced by Ab1–42 oligomers is also inhibited
in medium lacking extracellular Ca
2+ (Fig. 1F) and addition of
extracellular Ca
2+ restores the response. Ab25–35 and Ab1–42
oligomers increase [Ca
2+]cyt in 9069 and 8269% of the cells,
respectively. The maximum D[Ca
2+]cyt for responsive cells was
12906247 nM for Ab25–35 and 1050663 nM for Ab1–42
oligomers. In contrast, only 1264% of the cells responded to
Ab1–42 fibrils and the maximum D[Ca
2+]cyt for responsive cells was
258623 nM (data from 727 cells studied in 15 independent
experiments). Most cells showing a Ca
2+ response to Ab1–42
oligomers also respond to NMDA suggesting that responsive cells
are neurons rather than glia (Fig. 1F). To confirm this finding we
identified responsive cells by means of two-fold immunocyto-
chemistry against neurons and glia in the same microscopic field
used for Ca
2+ imaging. Fig. 1G shows a representative example in
which cells were identified by immunostaining (red, glia; green,
neurons; blue, nuclei) after Ca
2+ imaging. Neurons but not glia
undergo increases in [Ca
2+]cyt after presentation of Ab1–42
oligomers.
We have tested also the effects of Ab1–42 oligomers on [Ca
2+]cyt
in cortical and hippocampal neurons. Fig. 2 shows that Ab1–42
oligomers (500 nM) induce very large increases in [Ca
2+]cyt in both
cortical (Fig. 2A) and hippocampal neurons (Fig. 2B). Most cells
present in the microscopic fields responded to Ab1–42 oligomers in
both cortical (8369%, n=218 cells, 3 experiments) and
hippocampal (8762%, n=149 cells, 3 experiments) cells. In
addition, the same cells that responded to Ab1–42 oligomers also
responded to NMDA suggesting that responsive cells are neurons
rather than glia (Fig. 2). Taken together, the results indicate that
Ab25–35 and Ab1–42 oligomers promote massive Ca
2+ influx in
GT1 neural cells, cerebellar granules as well as cortical and
hippocampal neurons. In contrast, Ab1–42 fibrils, at concentrations
that are equally toxic than oligomers, produce no rises in [Ca
2+]cyt
indicating that the mechanism of neurotoxicity may be different as
proposed previously [21].
Ab oligomers induce mitochondrial Ca
2+ overload
We studied next whether Ab peptides promote also mitochon-
drial Ca
2+ uptake. We and others have reported previously that
[Ca
2+]mit may rise substantially and that most [Ca
2+]mit measure-
ments have been largely underestimated due to the use of non-
targeted probes with high affinity for Ca
2+ [22–24]. Accordingly,
we used bioluminescence imaging of neurons expressing a low-
affinity aequorin targeted to mitochondria developed previously to
monitor the high-[Ca
2+] levels inside the endoplasmic reticulum
(ER, 24). This probe contains also GFP to select transfected
neurons for bioluminescence imaging (mGA, 25). Fig. 3 shows the
fluorescence (GFP, top) and bioluminescence (aequorin, bottom)
images of cerebellar granule cells transfected with the mGA
plasmid. We reported previously that stimulation of sympathetic
Ab and Mitochondrial Ca
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PLoS ONE | www.plosone.org 2 July 2008 | Volume 3 | Issue 7 | e2718Figure 1. Ab1–42 oligomers but not fibrils induce Ca
2+ influx in neurons. A–B. GT1 neural cells and cerebellar granule cells were loaded with
fura2/AM and subjected to calcium imaging. Traces show the effects of Ab25–35 (20 mM) on [Ca
2+]cyt in three representative GT1 neural cells (A) and
cerebellar granule cells (B). Data representative of 141–233 cells studied in 4 and 3 independent experiments, respectively. C. The increase in [Ca
2+]cyt
induced by Ab25–35 (20 mM) in cerebellar granule cells is abolished in medium lacking extracellular Ca
2+ (No calcium). Addition of normal medium
containing 1 mM Ca
2+ restored the response to Ab25–35. High K
+ medium (150 mM K
+) induced a further increase in [Ca
2+]cyt. Traces correspond to
two individual cells representative of n=98 cells, 2 experiments). D.A b1–42 fibrils (2 mM) induced little or no [Ca
2+]cyt increase in cerebellar granule
cells. The same cells responded Ab25–35 (20 mM), N-methyl D-aspartate (100 mM NMDA) and high K
+ medium (150 mM K
+). (Traces correspond to four
individual cells representative of n=90 cells 3 experiments). E.A b1–42 oligomers (500 nM) induced a large and sustained increase in [Ca
2+]cyt in
cerebellar granules cells. Traces correspond to four individual cells representative of n=404 cells 5 experiments). F. The effects of Ab1–42 oligomers
(500 nM) are inhibited in medium lacking extracellular Ca
2+ (No calcium). Perfusion of medium containing Ca
2+ restored the response to Ab
oligomers. Cells also responded to 100 mM NMDA (recordings correspond to 5 individual cells representative of n=283 cells, 3 experiments). G.
Cerebellar granule cells were subjected to calcium imaging and then identified by double immunocytochemistry. Pictures show a bright field image
(scale bar represents 10 mm) and [Ca
2+]cyt levels before (resting calcium) and after treatment with Ab1–42 oligomers (oligomers) coded in pseudocolor
(pseudocolor bar from 0 to 2000 nM shown at left) and immunostaining of the cells. Glial cells (arrows) are coded in red, neurons are coded in green
and nuclei are coded in blue. Only neurons responded to Ab oligomers with a rise in [Ca
2+]cyt. Data representative of 249 cells, 3 experiments.
doi:10.1371/journal.pone.0002718.g001
Ab and Mitochondrial Ca
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chondria-targeted aequorin with high K
+ medium (to open
voltage-gated Ca
2+ channels) release typically 5–10% of photonic
emissions (expressed as the % of remaining counts) that, when
calibrated, reported increases in [Ca
2+]mit of about 100–300 mM.
In addition, these [Ca
2+]mit rises were limited to a pool of
mitochondria close to sites of Ca
2+ entry and release [16,23,25].
We found that, in marked contrast, Ab25–35 (Fig. 3A) and Ab1–42
oligomers (Fig. 3B) released nearly all photonic emissions in
responsive neurons which, after calibration, reported an average
increase in [Ca
2+]mit close to the mM level. Like the rises in
[Ca
2+]cyt, the increases in [Ca
2+]mit were heterogeneous in terms
of lag, size and kinetics. On average, Ab25–35 induced a [Ca
2+]mit
increase in 6763% of the cells (mean6SEM, 10086250 mM, 37
cells, 3 experiments) whereas 62610% of the neurons responded
to Ab1–42 oligomers with a large increase in [Ca
2+]mit
(9606200 mM, 36 cells, 3 experiments). In contrast, Ab1–42 fibrils
failed to induce any increase in [Ca
2+]mit (n=3 experiments, data
not shown) consistently with the lack of effects on [Ca
2+]cyt. The
rises in [Ca
2+]mit induced by Ab25–35 and Ab1–42 oligomers in
intact neurons were similar to the increase in [Ca
2+]mit induced by
perfusing permeabilized neurons with intracellular medium (see
Methods) containing 5 mMC a
2+. This rise was prevented by the
mitochondrial Ca
2+ uniporter blocker ruthenium red and by
collapsing the mitochondrial potential (DY) with 10 mM FCCP
(data not shown). Ab25–35 induced a similar large increase in both
[Ca
2+]cyt and [Ca
2+]mit in GT1 neural cells (data not shown). We
tested also the effects of Ab1–42 on [Ca
2+]mit in cortical neurons.
Ab1–42 oligomers also induced large [Ca
2+]mit increases in a large
population (7565%, n=91 cells, 6 experiments) of cortical
neurons (Fig. 3C). In the responsive cortical neurons, the average
rise in [Ca
2+]mit was 1099693 mM (mean6SEM). Taken
together, these results show that Ab25–35 and Ab1–42 oligomers,
but not fibrils, induce a large and sustained entry of Ca
2+ through
the plasma membrane followed by mitochondrial Ca
2+ overload in
all neuronal cell models tested here. We asked next whether Ab1–
42 oligomers induce apoptosis and cell death and if so, for the
possible role of mitochondrial Ca
2+ overload in that process.
Ab induces apoptosis and cell death in neurons
Since mitochondrial Ca
2+ overload may promote opening of the
mitochondrial permeability transition pore (mPTP) and the
intrinsic pathway to apoptosis [26,27], we have studied whether
exogenously added Ab1–42 oligomers promote apoptotic processes
in cerebellar granule cells. For assessing mPTP opening we used
the calcein/Co
2+ method [28]. Calcein fluorescence distributes in
both cytosol and mitochondria but only cytosolic calcein is
quenched by Co
2+. Opening of mPTP promotes mitochondrial
calcein quenching. Fig 4A shows that Ab1–42 oligomers induce
quenching of mitochondrial calcein fluorescence in cells loaded
with calcein and CoCl2 and this effect is prevented by cyclosporin
A, a mPTP blocker. Ab1–42 oligomers also promote release of
cytochrome c (Fig. 4B), apoptosis (Fig. 4C) and cell death (Fig. 4D)
as shown by conventional immunofluorescence against cyto-
chrome c, TUNEL assay and dye exclusion studies, respectively.
Cell death induced by Ab oligomers is inhibited by cyclosporin A
(Fig. 4D). Ab25–35 also induces apoptosis and cell death in
cerebellar granule cells (Figure S2). These results indicate that
Ab1–42 oligomers promote a mitochondrial pathway to apoptosis.
These effects are quite well mimicked by the toxic fragment Ab25–
35, although at far larger concentrations.
Mitochondrial Ca
2+ overload contributes to Ab-induced
apoptosis
We asked next for the contribution of mitochondrial Ca
2+
overload to the apoptosis induced by Ab1–42 oligomers and Ab25–
35. For this end we have studied whether inhibition of
mitochondrial Ca
2+ uptake prevents Ab oligomers-induced
apoptosis or not. Ca
2+ uptake by mitochondria depends
exponentially on DY, a huge driving force of 2180 mV built
Figure 2. Ab1–42 oligomers induce [Ca
2+]cyt increases in cortical and hippocampal neurons. Pictures show pseudocolor images of [Ca
2+]cyt
before (control) and after (oligomers) perfusion with 500 nM Ab1–42 oligomers in cortical (A) and hippocampal (B) neurons loaded with fura4F.
Pseudocolor scale shown at right. Traces are recordings of [Ca
2+]cyt in 5 representative cortical (A) and hippocampal (B) neurons during stimulation
with Ab1–42 oligomers. Cells responding to Ab1–42 oligomers also responded to 100 mM NMDA and 150 mM K
+. Data are representative of n=218
cortical cells and n=149 hippocampal cells studied in at least 3 independent experiments for each brain area.
doi:10.1371/journal.pone.0002718.g002
Ab and Mitochondrial Ca
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mitochondrial depolarization is enough to prevent largely
mitochondrial Ca
2+ uptake [29,30]. Accordingly, we studied the
effects of a small mitochondrial depolarization using low
concentrations of the mitochondrial uncoupler FCCP. To assess
the effects of this treatment on DY we used TMRM, a cationic dye
that accumulates in mitochondria according to DY and is
considered one of the most sensitive DY probes available [31].
Confocal images of cerebellar granule cells co-stained with
mitotracker green and TMRM show the mitochondrial localiza-
tion of the probe (Fig. 5A). Addition of FCCP decreases TMRM
fluorescence in a dose–dependent manner consistent with a
mitochondrial depolarization (Fig. 5B). At 100 nM, FCCP
decreases TMRM fluorescence by about 25% relative to the total
fluorescence decrease induced by 10 mM FCCP. According to our
previous report [30], we estimate that such a decrease in TMRM
fluorescence induced by 100 nM FCCP corresponds to a loss of
DY of about 10–20 mV; whereas at 10 mM, FCCP decreases fully
TMRM fluorescence consistently with a collapse of DY (Fig. 5C).
Similar results were found in GT1 neural cells (data not shown).
Strong plasma membrane depolarization with high K
+ medium
(50 mM) did not affect TMRM fluorescence excluding the
possibility that TMRM is reporting changes in the plasma
membrane potential (data not shown). Next, we studied the effects
of such an small mitochondrial depolarization on mitochondrial
Ca
2+ uptake. We found that FCCP, at 100 nM, prevents the
increase in [Ca
2+]mit induced by Ab1–42 oligomers (Fig. 5D).
Specifically, 100 nM FCCP inhibits by 7864% the [Ca
2+]mit
increase induced by Ab1–42 oligomers (n=21 cells, 3 experiments).
FCCP also inhibited the rise in [Ca
2+]mit induced by Ab25–35
(Figure S3A). Specifically, 100 nM FCCP inhibits by 8265% the
[Ca
2+]mit increase induced by Ab25–35 (17 cells studied, 3
experiments). This effect is not due to inhibition of Ca
2+ entry
through the plasma membrane since 100 nM FCCP does not
prevent at all the increase in [Ca
2+]cyt induced by Ab1–42
oligomers (Fig. 5E) or Ab25–35 (Figure S3B).
Once that conditions are established for specific inhibition of
mitochondrial Ca
2+ uptake, we addressed the contribution of
mitochondrial Ca
2+ overload to the cell death induced by Ab1–42
oligomers. For this end, we studied the effects of 100 nM FCCP on
Ab1–42 oligomers-induced cytochrome c release and cell death. We
find that FCCP at 100 nM prevents both cytochrome c release
Figure 3. Ab1–42 oligomers induce mitochondrial Ca
2+ overload. Cerebellar granule cells and cortical neurons were transfected with the low-
affinity, mitochondria-targeted aequorin fused to GFP, incubated with 1 mM n coelenterazine and subjected to bioluminescence imaging of [Ca
2+]mit.
Pictures show the fluorescence (top, GFP fluorescence) and accumulated photonic emissions (bottom, Aequorin Bioluminescence) images of
representative microscopic fields (scale bar represents 10 mm). Luminescence intensity is coded in pseudocolor (1 to 32 photons per pixel). Traces
show the effects of Ab25–35 (20 mM, A) and Ab1–42 oligomers (500 nM, B) on % of remaining counts (top traces) and calibrated [Ca
2+]mit (bottom
traces) in individual, representative cerebellar granule cells (A,B) and cortical neurons (C). Data are representative of 37, 36 and 68 individual cells
studied in 3 independent experiments, respectively.
doi:10.1371/journal.pone.0002718.g003
Ab and Mitochondrial Ca
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S3C,D). Consistently, we find that FCCP 100 nM inhibits cell death
induced by both Ab25–35 in cerebellar granule cells (Fig. 5H) and
GT1 cells (Fig. 5I). Finally, 100 nM FCCP also inhibits cell death
induced by Ab1–42 oligomers in cerebellar granule cells (Fig. 5J).
These results indicate that inhibition of mitochondrial Ca
2+
overload by a partial mitochondrial depolarization protects against
the neurotoxicity induced by Ab1–42 oligomers and Ab25–35.
It has been reported that mitochondrial Ca
2+ overload during
excitotoxicity may promote reactive oxygen species (ROS)
production and contribute to neuron cell damage [32]. Accord-
ingly, we also studied the effects of Ab1–42 oligomers on ROS
production in cerebellar granule cells. Incubation of cerebellar
granule cells with 500 nM Ab1–42 oligomers for 4 h elicited a clear
increase in number of neurons strongly stained by the ROS probe
CM-H2DCFDA. This effect was absent in cells incubated
previously with 100 nM FCCP added here to prevent the Ab1–
42 induced increase in [Ca
2+]mit (Figure S4). These results suggest
that mitochondrial Ca
2+ overload may contribute to ROS
production induced by Ab1–42 oligomers.
NSAIDs depolarize mitochondria and inhibit
mitochondrial Ca
2+ uptake
The above results open the question on whether drugs
preventing mitochondrial Ca
2+ overload may or may not protect
Figure 4. Ab1–42 oligomers induce mPTP opening, cytochrome c release, apoptosis and cell death. A. Mitochondrial permeability
transition was assessed directly by the calcein/Co
2+ method. Cerebellar granule cells were loaded with calcein/AM 1 mM and CoCl2 1 mM for 15 min
at 37uC and calcein fluorescence quenching was imaged. Traces correspond to mean6SEM fluorescence records normalized to the value before the
addition of oligomeric Ab1–42 (500 nM) in responsive cells (n=16 cells, vehicle) or in cyclosporin (1 mM) treated cells. Representative of 3 experiments.
B. Location of cytochrome c was assessed by immunofluorescence against cytochrome c. Cerebellar granule cells were cultured for 72 h in vehicle or
500 nM Ab1–42 oligomers. Blue colors show nuclei stained with DAPI. Green colors show location of cytochrome c. Control cells show punctate
distribution of cytochrome c. Ab oligomers-treated cells show a more diffuse location of cytochrome c due to release of cytochrome c from
mitochondria. Representative of 3 independent experiments. Scale bar represents 10 mm. C. Cerebellar granule cells were cultured for 72 h in vehicle
or Ab1–42 oligomers (500 nM) and apoptosis was tested by TUNEL assay. Pictures show nuclei (blue) and apoptotic cells (purple). Bars show % of
apoptotic cells. (n=3; *p,0 05). Scale bar represents 10 mm. D. Cerebellar granule cells were cultured for 72 h with vehicle (control) or Ab1–42
oligomers (500 nM) and cell death was assessed by staining with FDA (green living cells) and PI (red dead cells, scale bar represents 10 mm. Shown are
also the effects cyclosporin A (1 mM) on Ab1–42 oligomers-induced death in cerebellar granule cells (n=3;
ap,0 05 vs control;
bp,00 5v sA b1–42).
Representative of 3 independent experiments.
doi:10.1371/journal.pone.0002718.g004
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2+ uptake contributes to cell death induced by Ab oligomers. A. Cerebellar granule cells were co-loaded with
mitotracker green and TMRM 10 nM and washed. Double staining was assessed by confocal microscopy. Pictures show bright field mitotracker
staining, TMRM staining and merge of mitotracker and TMRM staining. Images confirm the mitochondrial location of the TMRM probe. Scale bar
represents 10 mm. B. Cells were loaded with TMRM 10 nM and mitochondrial depolarization was estimated by the decrease in TMRM fluorescence.
Pictures show TMRM fluorescence images of cerebellar granule cells treated for 5 min with vehicle (control), 100 nM FCCP or 10 mM FCCP. Scale bar
represents 10 mm. C. Traces show fluorescence recordings of cerebellar granule cells stained with 10 nM TMRM. Fluorescence values from individual
cells were normalized to the value before addition (arrow) of either vehicle or FCCP and averaged. Each trace is the mean of 45–67 cells and
representative of at least 3 independent experiments. D. Cerebellar granule cells expressing mGA were subjected to bioluminescence for [Ca
2+]mit
measurements. FCCP 100 nM inhibits the increase in [Ca
2+]mit induced by Ab1–42 oligomers (500 nM, 21 cells, 3 experiments). After washout of FCCP,
Ab1–42 oligomers were able to increase [Ca
2+]mit. E. Cerebellar granule cells were loaded with fura2/AM and subjected to fluorescence imaging for
[Ca
2+]cyt measurements. FCCP 100 nM failed to inhibit the increase in [Ca
2+]cyt induced by Ab1–42 oligomers (500 nM) (n=78 cells, 3 experiments). F.
Immunofluorescence against cytochrome c was assessed by confocal microscopy in cerebellar granule cells treated with vehicle (Control), Ab1–42
oligomers 500 nM (Ab) and Ab1–42 oligomers+FCCP 100 nM (Ab+FCCP) for 72 h. Ab1–42 oligomers promote diffusion of cytochrome c that otherwise
shows a punctate staining. 100 nM FCCP prevented diffusion of cytochrome C. Scale bar represents 10 mm. G. Bars show % of cells showing diffuse
staining for cytochrome c (reflecting cytochrome c release). Ab1–42 oligomers (500 nM) increase the % of cells showing diffuse staining, an effect
inhibited by FCCP 100 nM. H–J. FCCP 100 nM inhibits cell death induced by 20 mMA b25–35 in cerebellar cells (H) and GT1 cells (I) and by 500 nM Ab1–
42 oligomers in cerebellar granule cells (J) as assessed by dye exclusion studies.
ap,00 5vs. control; All data are mean6SEM of 3 independent
experiments.
doi:10.1371/journal.pone.0002718.g005
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that salicylate, the mayor aspirin metabolite, depolarizes mito-
chondria and inhibit mitochondrial Ca
2+ uptake in human colon
carcinoma cells at low, therapeutic concentrations [29,30].
Accordingly, we asked whether salicylate and other carboxylic
NSAIDs depolarize mitochondria and inhibit mitochondrial Ca
2+
uptake in cerebellar granule cells. Figs. 6A–C show that salicylate,
indomethacin and R-flurbiprofen decrease TMRM fluorescence
in a dose-dependent manner in intact neurons consistent with a
partial mitochondrial depolarization. Shown are also the effects of
10 mM FCCP (lowest traces in each panel in Figs. 6A–C), a
concentration that collapses the mitochondrial potential. A similar
mitochondrial depolarization than that provoked by 100 nM
FCCP (Fig. 5C) was elicited by 100 mM salicylate and by 0,1–
1 mM of the remaining NSAIDs including R-flurbiprofen, an
enantiomer derivative lacking anti-inflammatory activity. Next, we
studied the effects of NSAIDs on mitochondrial Ca
2+ uptake. We
find that salicylate, indomethacin and R-flurbiprofen inhibit the
mitochondrial Ca
2+ overload induced by either Ab25–35 in intact
cells or by 5 mMC a
2+ in permeabilized neurons (Fig. 6D–G).
Specifically, salicylate, at 100 mM, decreased by 7864% the Ab25–
35-induced [Ca
2+]mit rise in intact cells and by 7766% the Ca
2+-
induced rise in [Ca
2+]mit in permeabilized neurons (data from 157
cells studied in 4 independent experiments). Indomethacin,
sulindac sulfide and R-flurbiprofen, all tested at 1 mM, inhibited
by 7763, 8664 and 6861%, respectively, the Ca
2+-induced rise
in [Ca
2+]mit in permeabilized neurons (data from 188 cells studied
in 6 independent experiments). Salicylate and R-flurbiprofen also
prevented the [Ca
2+]mit rise induced by Ab1–42 oligomers
(Fig. 6H,I). Specifically, salicylate at 100 mM and R-flurbiprofen
at 1 mM inhibited by 7764% and 8563%, respectively (mean6-
SEM) the [Ca
2+]mit increase induced by Ab1–42 oligomers (n=35
Figure 6. NSAIDs depolarize mitochondria and inhibit mitochondrial Ca
2+ uptake. A–C. Cerebellar granule cells were stained with 10 nM
TMRE and subjected to fluorescence microscopy for monitoring changes in mitochondrial potential. Each trace correspond to averaged, normalized
fluorescence values of 34–42 cells treated (arrow) with vehicle (control) or different concentrations of salicylate (A, 10 mM to 2 mM), indomethacin (B,
0.1 to 10 mM), R-flurbiprofen (C, 0.1 to 10 mM). FCCP 10 mM was also added to compare with conditions of collapse of the mitochondrial potential.
Each series of recordings is representative of at least 3 experiments. D–F. Cerebellar granule cells were transfected with the mGA plasmid and
subjected to bioluminescence imaging for monitoring [Ca
2+]mit. Salicylate (D, 100 mM) inhibits the [Ca
2+]mit induced by Ab25–35 (20 mM, n=43 cells, 3
experiments). In some experiments, cerebellar granule cells expressing mGA were permeabilized in intracellular medium containing 200 nM Ca
2+ (see
methods) and treated with salicylate 100 mM (E), R-flurbiprofen 1 mM (F) or indomethacin 1 mM (G) before being stimulated with the same
intracellular medium containing 5 mMC a
2+ to stimulate mitochondrial Ca
2+ uptake (Data from 188 cells studied in 6 independent experiments). H,I.
Salicylate 100 mM and R-flurbiprofen 1 mM also inhibits the increase in [Ca
2+]mit induced by Ab1–42 oligomers (500 nM). Data from n=35 and 30 cells
respectively, studied in 3 independent experiments for each drug.
doi:10.1371/journal.pone.0002718.g006
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each drug). These results indicate that NSAIDs inhibit mitochon-
drial Ca
2+ uptake induced by Ab1–42 oligomers and Ab25–35 in
intact cells and by high Ca
2+ in permeabilized cells. In addition,
they suggest that this effect is probably secondary to mitochondrial
depolarization and therefore, inhibition of the driving force for
Ca
2+ uptake through the mitochondrial Ca
2+ uniporter, rather
than inhibition of Ca
2+ entry through the plasma membrane. To
support further this view we assessed the effects of NSAIDs on the
increases in [Ca
2+]cyt induced by Ab1–42 oligomers and Ab25–35.
None of the NSAIDs tested including indomethacin, R-flurbipro-
fen and sulindac sulfide, all tested at 1 mM, produce any change in
resting [Ca
2+]cyt or prevent the increase in [Ca
2+]cyt induced by
Ab1–42 oligomers (Fig. 7A–C) or Ab25–35 (Fig. 7D–G). Moreover,
addition of NSAID (salicylate) over the increased [Ca
2+]cyt
induced by Ab25–35 not only failed to decrease the level of
[Ca
2+]cyt but rather increased it (Fig. 7H), an effect that can be
explained by mitochondrial uncoupling and release of Ca
2+ from
preloaded mitochondria [33]. Because a large mitochondrial
depolarization may affect cell metabolism, we tested whether or
not the small depolarization induced by low concentrations of
FCCP and NSAIDs may affect cell ATP levels. Fig. 7I shows that
neither FCCP (100 nM), salicylate (100 mM) or R-flurbiprofen
(1 mM) decrease the cell ATP levels in cerebellar granule cells.
These results indicate that NSAIDs, at low mM concentrations,
inhibit specifically mitochondrial Ca
2+ uptake without preventing
entry of Ca
2+ through the plasma membrane and this effect is most
likely mediated by a partial mitochondrial depolarization. We
recently adapted an algorithm to convert TMR fluorescence
values into estimated DY expressed in mV [30]. According to that
algorithm, we estimate that the loss of DY induced by the low
FCCP and NSAIDs concentrations used here is only 10–20 mV.
Figure 7. NSAIDs do not prevent the increase in [Ca
2+]cyt induced by Ab1–42- oligomers or affect cell ATP levels. A–C, cerebellar granule
cells were loaded with fura4F/AM and subjected to calcium imaging to test the effects of several NSAIDs on the increases in [Ca
2+]cyt induced by Ab1–
42 oligomers. Neither indomethacin (A), R-flurbiprofen (B) or sulindac sulfide (C), all tested at 1 mM, inhibit the increase in [Ca
2+]cyt induced by Ab1–42
oligomers. Data corresponds to 76–120 cells, corresponding to at least 2 experiments. D–G, indomethacin, R-flurbiprofen or sulindac sulfide (all tested
at 1 mM) neither inhibit the increase in [Ca
2+]cyt induced by Ab25–35. Shown are representative recordings of individual cells (46–90 cells studied in 3
independent experiments respectively). G. The maximum increase in [Ca
2+]cyt induced by Ab25–35 (20 mM) was calculated for cells treated with vehicle
(control) or the above NSAIDs (p.0,05; n=3). H. Salicylate 100 mM increased [Ca
2+]cyt further in cells treated with Ab25–35 (20 mM). Representative
recordings of 164 cells studied in 3 independent experiments. I. Cerebellar granule cells were treated with vehicle, 1 mM R-flurbiprofen, 100 mM
salicylate and 100 nM FCCP for 72 h and cell ATP levels were measured. None of the treatments decreases significantly cell ATP levels (p.0,05; n=3).
doi:10.1371/journal.pone.0002718.g007
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mise cell metabolism as suggested by the lack of effects of these
treatments on cell ATP levels.
NSAIDs prevent neuron cell death induced by Ab1–42
oligomers
To learn whether inhibition of mitochondrial Ca
2+ uptake by
NSAIDs prevents cell death induced by Ab1–42 oligomers, we have
studied the effects of the same low NSAID concentrations on Ab1–
42 oligomers-induced cytochrome c release and cell death. We
found that 1 mM R-flurbiprofen and 100 mM salicylate prevent
cytochrome c release induced by Ab1–42 oligomers (Fig. 8A,B). R-
flurbiprofen and salicylate prevent also cytochrome c release
induced by Ab25–35 (Figure S5A–C). In addition, we found that
100 mM salicylate inhibits cell death induced by Ab25–35 in both
cerebellar granule cells (Fig. 8C) and GT1 cells (Fig. 8D).
Salicylate also inhibits cell death induced by Ab1–42 oligomers in
cerebellar granule cells (Fig. 8E). Moreover, we found that 1 mM
of either ibuprofen, indomethacin and sulindac sulfide prevented
Figure 8. NSAIDs inhibit cytochrome c release and cell death induced by Ab1–42 oligomers. A,B. Cerebellar granule cells were treated with
Ab1–42 (500 nM) for 72 h with or without 1 mM R-flurbiprofen or 100 mM salicylate and fixed for analysis of cytochrome c location using confocal
microscopy. A. Control cells showed a punctate distribution of cytochrome c. Scale bar represents 10 mm. Ab1–42 oligomers-treated cells show a more
diffuse pattern of cytochrome c whereas cells treated with Ab1–42 oligomers plus R-flurbiprofen show a punctate pattern similar to control cells. B.
Bars show the relative abundance (%) of cells showing diffuse immunostaining in control cells, cells treated with Ab1–42 oligomers and cells treated
with Ab1–42 oligomers plus 1 mM R-flurbiprofen or 100 mM salicylate (B). *p,0 05 vs control; #p,00 5v sA b; data from at least 3 independent
experiments. Salicylate 100 mM inhibits cell death induced by Ab25–35 (20 mM) in cerebellar granule cells (C) and GT1 cells (D). Salicylate 100 mM also
inhibits cell death induced by Ab1–42 oligomers (500 nM) in cerebellar granule cells (E). (*p,0 05 vs control; #p,00 5v sA b. n=3). F. Ibuprofen (Ibu),
Indomethacin (Indo), and sulindac sulfide (Sul), all tested at 1 mM, inhibit cell death induced by Ab1–42 oligomers (500 nM) in cerebellar granule cells.
G. R-Flurbiprofen 1 mM also inhibits cell death induced by Ab1–42 oligomers (500 nM). *p,00 5vs. control;
#p,00 5vs Ab. All data are representative
of 3 experiments.
doi:10.1371/journal.pone.0002718.g008
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and Ab25–35 (Figure S5D). R-flurbiprofen prevented cell death
induced by either Ab1–42 oligomers (Fig. 8G). In addition, R-
flurbiprofen prevented cell death induced by Ab25–35 to the same
extent than the S enantiomer (Figure S5E). Thus, NSAIDs inhibit
cytochrome c release and cell death induced by either Ab1–42 and
Ab25–35 at the same low concentrations that depolarize partially
mitochondria and inhibit mitochondrial Ca
2+ overload. Finally,
we found that 1 mM R-flurbiprofen, like 100 nM FCCP, also
inhibits ROS production induced by Ab1–42 oligomers (Figure S4).
Discussion
We show here that Ab1–42 oligomers, the assembly state that
correlates best with brain damage and cognitive deficits in AD
[13,14], but not Ab fibrils, promote massive entry of Ca
2+ into
GT1 neural cells and cerebellar granule neurons but not glia. This
view is supported by the finding that cells responding to Ab1–42
oligomers also respond to NMDA and by immunocytochemical
identification of responsive cells. Ab1–42 oligomers, but not fibrils,
also induced large increases in [Ca
2+]cyt in cortical and
hippocampal neurons. These results agree with those recently
reported [34] showing that Ab1–42 oligomers but not monomers or
fibrils increased [Ca
2+]cyt in a human neuroblastoma cell line. The
results suggest that the mechanism of neurotoxicity by fibrils and
oligomers may be different as previously proposed [21]. The
effects of Ab1–42 oligomers are quite well reproduced by the toxic
fragment Ab25–35 although at 40-fold larger concentrations. The
increases in [Ca
2+]cyt induced by Ab1–42 oligomers and the toxic
fragment Ab25–35 can be attributed to enhanced entry of
extracellular Ca
2+ through the plasma membrane rather than
release from intracellular Ca
2+ stores as they were entirely
prevented by removal of extracellular Ca
2+. The route for this
enhanced Ca
2+ influx is not solved yet but candidate mechanisms
may include plasma membrane permeabilization [34], formation
of the so-called amyloid channels [35,36] and/or activation of
NMDA receptors [37]. Neither Ab25–35 or Ab1–42 oligomers
induced parallel decreases in fura2 fluorescence excited at 340 and
380 nm (data not shown) suggesting that the rises in [Ca
2+]cyt are
not due to membrane permeabilization. It has been shown
previously that the increases in [Ca
2+]cyt induced by Ab species
can be prevented by the NMDA receptor open channel blocker
memantine [37] and specific amyloid channel blockers [36]
suggesting that both NMDA receptors and amyloid channels
might be involved. In any case, the massive entry of Ca
2+ induced
by Ab1–42 oligomers promotes mitochondrial Ca
2+ overload as
shown directly by bioluminescence imaging of neurons expressing
a low-affinity aequorin targeted to mitochondria. This probe was
originally developed to monitor the high [Ca
2+] inside the
endoplasmic reticulum that reach the mM range in resting
conditions [24]. Using this probe, we and others have shown
previously that [Ca
2+]mit may reach several hundred mM upon
stimulation of voltage-gated Ca
2+ entry and Ca
2+ release from
intracellular stores [16,23,24]. However, the above mentioned
increases in [Ca
2+]mit were transient and restricted to a pool of
mitochondria close to sites of Ca
2+ entry or release [23,24]. The
recent introduction of low-affinity, targeted chameleons [38] has
confirmed that [Ca
2+]mit may reach values above 200 mM, the
sensitivity limit of these probes, stressing that [Ca
2+]mit levels
actually rise substantially and the requirement of low-affinity
probes for actual measurements of [Ca
2+]mit, particularly when a
mitochondrial Ca
2+ overload is to be measured. Using the low-
affinity, mitochondria-targeted aequorin, we find that Ab25–35 and
Ab1–42 oligomers, but not fibrils, induce a massive mitochondrial
Ca
2+ overload that reaches values close to the mM level. As
aequorin is consumed by the high Ca
2+ level achieved, the results
suggest that, at variance with stimulation with high K
+, most
mitochondria take up Ca
2+ when cells are stimulated by Ab1–42
oligomers. As mitochondrial Ca
2+ uptake through the mitochon-
drial Ca
2+ uniporter requires high [Ca
2+]cyt levels, these results
suggest that Ab1–42 oligomers promote a massive entry of Ca
2+,
large and sustained enough to activate the mitochondrial Ca
2+
uniporter of most mitochondria.
It has been reported that mitochondrial Ca
2+ overload may
promote mPTP opening and apoptotic cell death [26,39]. Our
results indicate that mitochondrial Ca
2+ overload contributes to
the apoptotic cell death induced by Ab oligomers. This view is
supported by the findings that Ab1–42 oligomers promote i)a
mitochondrial Ca
2+ overload in the whole mitochondrial popula-
tion, ii)mitochondrial calcein quenching in a cyclosporin sensitive
manner, iii)release of cytochrome c, iv)apoptosis as determined by
TUNEL assay and v)cell death, again in a cyclosporin A-sensitive
manner. Furthermore, inhibition of mitochondrial Ca
2+ uptake by
low concentrations of FCCP inhibit both cytochrome c release and
cell death without preventing Ab1–42 oligomers-induced increases
in [Ca
2+]cyt or decreasing cell ATP levels. Finally, Ab1–42
oligomers induce ROS production and this effect is prevented
by low concentrations of FCCP. Taken together, our results
suggest that the large and sustained entry of Ca
2+ induced by Ab1–
42 oligomers, an effect mimicked by larger concentrations of the
toxic fragment Ab25–35, activate the mitochondrial Ca
2+ uniporter
of most mitochondria leading to a mitochondrial Ca
2+ overload.
This effect may promote mPTP opening by itself or, cooperate
with the excess of ROS production promoted by the own
mitochondrial Ca
2+ overload. Finally, mPTP opening allows
release of pro-apoptotic factors including cytochrome c leading to
apoptosis and cell death (see proposed model in Fig. 9). This view
resembles the mechanism of excitotoxicity reported for glutamate.
In fact, glutamate-induced neuron death requires mitochondrial
Ca
2+ uptake [40]. In addition, low concentrations of FCCP have
been reported to prevent mitochondrial Ca
2+ uptake and cell
death induced by NMDA [41]. Finally, glutamate induces also
ROS production and this effect is prevented by mitochondrial
uncoupling and blockers of the mitochondrial Ca
2+ uniporter [32].
Whereas this mechanism may contribute largely to cell death
induced by Ab oligomers, our results do not exclude that
additional mechanisms might contribute to this toxicity. For
example, it has been reported that intracellular Ab species may
also interact with mitochondria in AD mouse models and affected
AD brains [7–9] and this interaction may promote apoptosis and
cell death. It remains to be established whether mitochondrial
alterations induced by mitochondria-bound Ab species cooperate
with mitochondrial Ca
2+ overload to promote cell death.
The above findings indicate that mitochondrial Ca
2+ overload
contributes to the neurotoxicity induced by Ab1–42 oligomers.
Accordingly, any strategy intended to prevent specifically
mitochondrial Ca
2+ uptake could potentially protect neurons
against Ab1–42 oligomers toxicity. Among the most promising
agents for neuroprotection against AD are a series of classic
NSAIDs [5,42,43]. Recent evidence indicates that neuroprotection
afforded by NSAIDs is due to a mechanism other than their anti-
inflammatory activity. This view is based in that some, but not all
NSAIDs show neuroprotection and that structural analogs of
classic NSAIDs lacking anti-inflammatory activity like, for
instance, R-flurbiprofen, offer protection as well [43]. Some
NSAIDs including R-flurbiprofen have been reported to target
and inhibit c-secretase activity at rather large concentrations
(100 mM) leading to a lower Ab burden [44,45]. We show here
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mitochondria to the same extent than low concentrations of
FCCP, inhibit mitochondrial Ca
2+ overload induced by Ab
oligomers without preventing Ca
2+ entry through the plasma
membrane, prevent ROS production induced by Ab1–42 oligomers
and inhibit Ab oligomers-induced cytochrome c release and cell
death. Accordingly we propose a novel mechanism of neuropro-
tection against soluble Ab1–42 species by non-specific NSAIDs
based on the primary inhibition of mitochondrial Ca
2+ overload
and prevention of the ensuing mPTP opening an downstream
steps to cell death (Fig. 9). Notice that, at these low concentrations,
NSAIDs have little or no effect on c-secretase activity whereas
fitting the concentration range achieved in brains by human
therapeutic dose [45]. We must stress that these results have been
obtained mainly in cerebellar granule cells, a brain area generally
considered not affected earlier in AD. However, as mentioned
above, neuropathological studies have shown frequent and varied
cerebellar changes in the late stages of the disease [1].
Nevertheless, we show that Ab1–42 oligomers also induced large
increases in [Ca
2+]cyt and [Ca
2+]mit in cortical neurons as well as
rises in [Ca
2+]cyt in hippocampal neurons.
The mechanism of inhibition of mitochondrial Ca
2+ uptake by
NSAIDs is most likely mediated by mitochondrial depolarization.
This view is supported by i)the chemical structure of NSAIDs
resembling mitochondrial uncouplers, ii)the release of Ca
2+
induced by salicylate in Ca
2+-overloaded cells and iii)direct
TMRM fluorescence measurements showing NSAID-induced
mitochondrial depolarization. In addition, uncoupling activity is
considered a common characteristic of anti-inflammatory agents
with an ionizable group [46]. It may seem surprising that a small
mitochondrial depolarization be enough to inhibit largely
mitochondrial Ca
2+ uptake. However, several facts support this
view. First the Ca
2+ channel associated to the mitochondrial Ca
2+
uniporter is inwardly rectifying, making it especially effective for
Ca
2+ uptake into energized mitochondria [47]. In this scenario, a
mild mitochondrial depolarization will decrease largely the Ca
2+
current through the mitochondrial Ca
2+ uniporter. Second, the
Nernst’s equilibrium for Ca
2+ across mitochondria predicts that a
50% fall in DY reduces the free mitochondrial [Ca
2+] that can be
reached at equilibrium by 1,000 fold [23]. This prediction is based
on the huge DY built in respiring mitochondria and the fact that
Ca
2+ is a divalent cation present at extremely low concentrations
(100 nM) in resting mitochondria. Thus, it is thermodynamically
possible that even small drops in DY could influence dramatically
the [Ca
2+]mit increase achieved during cell stimulation. In support
of this view, we have shown recently that small drops in DY of a
few tens of mVs are enough to prevent largely mitochondrial Ca
2+
uptake [30].
Interestingly, other AD-related factors seemingly independent of
Ab species may contribute as well to mitochondrial Ca
2+ overload
and, perhaps, to neurotoxicity. For example, in familial AD, loss of
function presenilin 1 mutants show exaggerated Ca
2+ release from
intracellular stores due to either defective Ca
2+ leak from the ER
or increased activity of Ca
2+ release channels at ER [48–50, but
see also 51 for alternative results]. The close coupling between ER
and mitochondria [52] may favor mitochondrial Ca
2+ overload in
patients carrying these mutations. Further research is required to
support this view. If that were the case, the possible PS1 mutation-
mediated mitochondrial Ca
2+ overload and ensuing neuron
damage should be limited by NSAIDs. An even more important
factor, at least from the point of view of the potential number of
patients affected, could be the reported depletion of endogenous
Ca
2+ buffers, particularly calbindinD28k, in selected brain regions
during aging and sporadic AD [53,54]. A diminished cytosolic
Ca
2+ buffer capacity may place mitochondria at risk of Ca
2+
overload during normal neural activity, a process that should be
ameliorated by NSAIDs. Therefore, our results point to a pivotal
role of mitochondrial Ca
2+ overload in Ab1–42 oligomers toxicity
and AD. Interestingly, the mitochondrial Ca
2+ overloads likely
induced by AD related processes such as Ab oligomers (shown
here), excitotoxicity [40], excess Ca
2+ release from ER [49] and
loss of endogenous Ca
2+ buffers [53,54] could be all ameliorated
by low NSAID concentrations, regardless of the source of Ca
2+
excess being either intracellular or extracellular.
Materials and Methods
Materials
Wistar rats were obtained from the Valladolid University
animal facility. Fura2/AM, TMRM, DAPI, CM-H2DCFDA, n
coelenterazine, the cytochrome c antibody, Alexa 488 a mouse
IgG and Alexa F594 a rabbit IgG were purchased from Invitrogen
(Barcelona, Spain). DMEM (ref. 41966-029), fetal bovine serum,
horse serum, neurobasal medium, B27, penicillin and streptomy-
cin are from Gibco (Barcelona, Spain). Papain solution is from
Worthington (Lakewood, NJ). The kit for TUNEL assay is from
Roche Diagnostics (Penzberg, Germany). Ab peptides were
purchased from Bachem AG (Bubendorf, Switzerland). The
mouse anti b-tubulin III is from Covance (Princeton, USA) and
the rabbit anti-GFAP is from Sigma (Madrid, Spain). The mGA
plasmid was kindly donated by P. Brulet (Gif-sur-Yvette, France).
Hypothalamic GT1 neural cells were provided by R. Weiner (San
Francisco, USA). Other reagents and chemicals were obtained
either from Sigma or Merck.
Figure 9. A model of Ab-induced toxicity and neuroprotection
by NSAIDs based on mitochondrial Ca
2+.A b1–42 oligomers and the
toxic fragment Ab25–35 induce a large entry of Ca
2+ through the plasma
membrane likely mediated by formation of amyloid channels and/or
NMDA receptors. This entry promotes in a sequential manner
mitochondrial Ca
2+ overload, ROS production, mPTP opening, cyto-
chrome c release, apoptosis and cell death. Other factors related to AD
may favor mitochondrial Ca
2+ overload including exaggerated IP3-
induced release of Ca
2+ from the ER in loss of function PS1 mutants
related to familial AD and/or decreased abundance of endogenous Ca
2+
buffers as calbindinD28k during aging or sporadic AD. NSAIDs, at low
concentrations (1 mM), depolarize partially mitochondria and inhibit
mitochondrial Ca
2+ overload, thus preventing cytochrome c release and
apoptosis induced by Ab oligomers.
doi:10.1371/journal.pone.0002718.g009
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Cerebellar granule cells were obtained from 5-day old Wistar
rat pups killed by dislocation followed by decapitation as reported
previously [55]. Cortical neurons were obtained from P0 Wistar
rat pups following the protocol reported by Murphy et al. [56].
Hippocampal neurons were prepared from P0 Wistar rat pups as
reported by Brewer et al. [57] with the modifications introduced by
Perez-Otano et al. [58]. Briefly, after brain removal, meninges
were discarded and the hippocampus was separated from cortex.
Hippocampal tissue was cut in small pieces, transferred to papain
solution and incubated at 37u C for 30 minutes with occasional
gentle shaking. Tissue pieces were washed with neurobasal
medium and dissociated into a single cell suspension. Hippocam-
pal cells were plated onto collagen-coated, 12 mm diameter glass
coverslips at 40610
3 cells/dish, and grown in Neurobasal Medium
supplemented with B27 and 10% horse serum. Cells were cultured
for 7–10 days before experiments. Cerebellar granule cells and
cortical neurons were plated on poly-L-lysine coated, 12 mm
diameter glass coverslips and cultured in high-glucose, low K
+,
Dulbeccos modified Eagles medium (DMEM, ref. 41966-029.
Gibco, Spain) plus 10% fetal bovine serum, 5% horse serum, 100
um l
21 penicillin and 100 mgm l
21 streptomycin for 2 days. Then
the culture medium was replaced by Satos medium [59] plus 5%
horse serum to avoid excessive proliferation of glia and cultured
for 2–4 (cerebellar) or 3–5 (cortical) days before experiments. GT1
neural cells were grown in DMEM with 10% fetal bovine serum,
5% horse serum, 100 u ml
21 penicillin and 100 mgm l
21
streptomycin.
Preparation of Ab oligomers and fibrils
Ab1–42 oligomers and fibrils were prepared as reported
previously by Klein and Dahlgren et al. [17,20]. Briefly, Ab1–42
was initially dissolved to 1 mM in hexafluoroisopropanol and
separated into aliquots in sterile microcentrifuge tubes. Hexa-
fluoroisopropanol was removed under vacuum in a speed vac.,
and the peptide film was stored desiccated at 220uC. For the
aggregation protocol, the peptide was first resuspended in dry
dimethyl sulfoxide to a concentration of 5 mM and treated
differently for preparation of oligomers and fibrils. For preparation
of oligomers, Hams F-12 was added to bring the peptide to a final
concentration of 100 mM and incubated at 4uC for 24 h. The
preparation was then centrifuged at 14,0006g for 10 min at 4uC
to remove insoluble aggregates (protofibrils and fibrils) and the
supernatants containing soluble Ab1–42 oligomers were transferred
to clean tubes and stored at 4uC. For preparation of fibrils, the
peptide resuspended in dimethyl sulfoxide at 5 mM concentration
was diluted in 10 mM HCl to bring the peptide to a final
concentration of 100 mM and incubated at 37uC for 24 h. Actual
concentrations of both oligomers and fibrils were measured by
amino acid analysis. Ab25–35 was solved in PBS at a concentration
of 1 mM, sonicated 3 times and stored at 220uC. For
experiments, Ab25–35 was solved in medium at a final concentra-
tion of 20 mM.
Amino Acid analysis
Samples of both Aß1–42 oligomers and fibrils in glass tubes were
extensively vacuum dried in a speed-vac. Hydrolysis was
performed using a 5.9 HCl solution containing 0.1% phenol.
Norleucine was added to the hydrolytic solution as an internal
standard. The tubes were sealed under vacuum and the hydrolysis
was performed during 24 h at 110uC. Subsequently, the samples
were vacuum dried. Finally, the samples were injected into a
Biochrom 30 amino acid analyzer. Both composition and
concentration data was obtained from the chromatogram.
PAGE-SDS and silver staining
A standard 17% PAGE-SDS was prepared and 10 ml samples of
either Ab1–42 oligomers or fibrils at a 40 mM concentration were
incubated with 1X loading buffer. The samples were loaded in the
gel without boiling and the gel was run at constant amperage of
20 mA. The gels were subsequently fixed with a freshly prepared
solution of 50% methanol, 12% acetic acid, 0.02% paraformal-
dehyde for at least 1h. Then, the gel was washed three times with
50% ethanol. The next step consisted on an incubation of the gel
for 1 min in 0.2 mg/ml NaS2O3. Subsequently, the gel was
washed three times with miliQ water for 20 seconds. Then, the gel
was incubated for 20 minutes in 2 mg/ml AgNO3 in 0.025%
formaldehyde. After two 20-second washes with miliQ water, color
was allowed to develop using a solution consisting of 60 mg/ml
Na2CO3, 0.02% formaldehyde, 0.004 mg/ml NaS2O3. After the
bands appear, the gel was washed twice with miliQ water and the
reaction was stopped using a 50% methanol, 12% acetic acid
solution.
Electron microscopy
A1 0ml sample of Aß1–42 fibrils (40 mM) was applied to a 200
mesh Formvar-coated copper grid and incubated for 15 minutes
at room temperature. The sample was then wicked off with filter
paper, washed briefly by placing the grid face down on a droplet of
water, and stained by transferring the grid face down on a droplet
of 2% uranyl acetate for 2 minutes before wicking off the solution
and air drying. Grids were visualized in a JEOL transmission
electron microscope.
Fluorescence imaging of [Ca
2+]cyt and in situ
immunofluorescence
Coverslips containing cells were incubated in standard medium
containing (in mM) NaCl 145, KCl 5, CaCl2 1, MgCl2 1, glucose
10 and Hepes 10 (pH, 7.42) and loaded with 4 mM fura2/AM or
fura4F/AM for 60 min at room temperature. Then coverslips
were placed on the heated stage of an inverted microscope (Nikon
Diaphot), perfused continuously with the same prewarmed
standard medium containing and epi-illuminated alternately at
340 and 380 nm. Light emitted above 520 nm was recorded with
a Magical Image Processor (Applied Imaging). Pixel by pixel ratios
of consecutive frames were captured and [Ca
2+]cyt was estimated
from these ratios as previously reported [16]. For differential
identification of neurons and glia, the single cell content of b-
tubulin III and glial fibrillary acidic protein (GFAP) were assessed
by indirect inmunofluorescence in the same cells used for calcium
imaging as reported previously [55]. Briefly, after calcium
imaging, cells were fixed with p-formaldehyde and incubated
with anti b tubulin III (1:400) and anti GFAP (1:200) for 1 h at
37uC. Then, cells were washed and incubated with 1:100 labeled
anti IgG antibodies. Nuclei were stained by incubation with DAPI
0,2 mg/ml for 5 min.
Bioluminescence imaging of [Ca
2+]mit
Cells were transfected with the mGA plasmid using a
Nucleofector II
H device and the VPG-1003 transfection kit
(Amaxa Biosystems, Cologne, Germany). The mGA probe contain
a mutated, low affinity aequorin targeted to mitochondria and a
GFP sequence to help select transfected neurons [25]. After 24 h,
cells were incubated for 1 h with 1 mM n coelenterazine, washed
and placed into a perfusion chamber thermostated to 37
uC under
a Zeiss Axiovert S100 TV microscope and perfused at 5–10 ml/
min with test solutions based on the standard perfusing solution
described above prewarmed at 37uC. At the end of each
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10 mM CaCl2 to release all the residual aequorin counts.
Bioluminescence images were taken with a Hamamatsu VIM
photon counting camera handled with an Argus-20 image
processor. Photonic emissions were integrated for 10 s periods.
Photons/cell in each image were quantified using the Hamamatsu
Aquacosmos software. Total counts per cell ranged between 2?10
3
and 2?10
5 and noise was (mean6SD) 161 counts per second
(c.p.s.) per typical cell area (2000 pixels). Data were first quantified
as rates of photoluminescence emission/total c.p.s remaining at
each time (% of remaining counts) and divided by the integration
period (L/LTOTAL in s
21). Emission values of less than 4 c.p.s were
not used for calculations. Calibrations in terms of [Ca
2+]mit were
performed using as reported previously [23]. In some experiments,
cells were permeabilized with digitonin 20 mM in ‘‘intracellular’’
medium of the following composition 130 mM KCl, 10 mM
NaCl, 1 mM MgCl2, 1 mM K3PO4, 0,2 mM EGTA, 1 mM ATP,
20 mM ADP, 2 mM succinate, 20 mM HEPES/KOH, pH, 6.8.
Then, the cells were incubated with the same medium containing
200 nM Ca
2+ (buffered with EGTA) with or without NSAIDs for
5 min. Then, perfusion was switched to ‘‘intracellular’’ medium
containing 5 mMC a
2+ (with or without NSAID). Further details
have been reported previously [16,23,25].
Mitochondrial permeability transition pore (mPTP)
mPTP opening was assessed directly by the calcein/cobalt
method [28]. Cells were co-loaded with calcein-AM 1 mM and
CoCl2 1 mM for 30 min at 37uC and subjected to conventional
fluorescence imaging or confocal microcopy. Fluorescence traces
from individual cells were normalized relative to the value before
addition of test solutions and averaged. Background fluorescence
corresponding to regions of interest devoid of cells was subtracted.
In some experiments, cells were incubated with cyclosporin A
1 mM for 15 min before recordings.
ROS Formation
ROS formation was evaluated in live neurons using CM-
H2DCFDA as reported by De Felice et al. [37]. Cerebellar granule
cell cultures were incubated for 4 h at 37uC with vehicle or 500
nM Ab1–42 in the absence or in the presence of FCCP 100 nM and
R-flurbiprofen 1 mM. ROS formation was assessed using 2 mM
CM-H2DCFDA with 40 min of probe loading. Then neurons
were superfused for 5 min with prewarmed (37uC) PBS.
Fluorescence in cells was immediately visualized using the Zeiss
S100 TV inverted microscope, a FITC filter set, an OrcaER
digital camera from Hamamatsu and the Hamamatsu Aqua-
cosmos software.
Mitochondrial potential (DY)
The effects of treatments on DY were estimated by fluorescence
imaging in cells loaded with the DY sensitive probe TMRM as
reported previously [29–31]. Briefly, cells were loaded with
TMRM (10 nM) for 30 min at room temperature, placed on the
perfusion chamber of a Zeiss Axiovert S100 TV inverted
microscope and superfused continuously with the prewarmed
(37uC) standard medium described above. Fluorescence images
were taken at 10 s intervals with a Hamamatsu VIM photon
counting camera handled with an Argus-20 image processor.
Traces from individual cells were normalized relative to the value
before the addition of either vehicle or treatment and averaged.
Background fluorescence -after collapse of the mitochondrial
potential induced by 10 mM FCCP- was subtracted. Location of
TMRM staining and fluorescence intensity ratios of TMRM in
mitochondrial and cytosolic areas was tested by confocal
microcopy in cells stained with both TMRM and mitotracker
green.
Cytochrome c release
Cytochrome c release from mitochondria was tested by
immunofluorescence and conventional or confocal microscopy.
Cells were treated under the various experimental conditions for
72 h and fixed. Location of cytochrome c was tested by indirect
immunofluorescence. In conventional fluorescence, nuclei were
identified by DAPI staining. Confocal images were obtained using
a BIO-RAD laser scanning system (Radiance 2100) coupled to a
Nikon eclipse TE2100U, inverted microscope. For quantification
of cytochrome c release by confocal microscopy, the relative
abundance (%) of cells showing diffuse vs. punctate immunoflu-
orescence was calculated [60].
Cell death and apoptosis
Cells were plated in wells at about 5610
4 cells/ml and treated
with test solutions for 72 h. Cell death was estimated in the same
samples by staining with fluorescein diacetate (FDA, 50 mg/ml,
3 min) and propidium iodide (PI, 20 mg/ml, 30 s) and assessed by
fluorescence microscopy using a Nikon Eclipse 80i microscope
coupled to a DM 1200C digital camera using a 20x objective. For
determination of apoptotic cells at the single cell level, cells were
plated at about 5610
4 cells/ml and incubated with test solutions
for 72 h. Apoptotic cells were revealed by the terminal
deoxynucleotidyl transferase-mediated dUTP nick-end labeling
(TUNEL) method by fluorescence imaging and a cell death
detection kit following the protocol provided by the manufacturer.
Cell ATP levels
Cerebellar granule cells were plated in 4-well plates and
cultured with test solutions for 72 h. Then, cells were washed
twice with PBS at 37uC and 1 ml of boiling 20 mM Tris, pH, 7.75
and 4 mM EDTA was added. After 2 min, samples were
centrifuged for 4 min at 10.000 g. ATP was measured later from
the supernatant by the luciferin-luciferase assay using a Cairn
photon counting device (Cairn Research, UK) and a standard
curve prepared using pure ATP over a 10
25 to 10
29 M
concentration range.
Statistics
When only two means were compared, Student’s t test was used.
For more than two groups, statistical significance of the data was
assessed by ANOVA and compared using Bonferroni’s multiple
comparison test. Differences were considered significant at
p,0,05.
Supporting Information
Figure S1 Characterization of Ab oligomers and fibrils.
A. SDS-PAGE and silver staining of an oligomeric Ab1–42 sample.
Arrows point to bands reflecting the presence of monomers,
dimers and tetramers. Representative of 3 experiments. B, SDS-
PAGE and silver staining of a fibrillar Ab1–42 sample. Arrows
point to bands reflecting the presence of monomers, dimers,
tetramers. Some larger oligomerization species also are apparent
in the gel. In addition, a certain amount of large molecular weight
fibrils incapable of entering the separating gel is also pointed on
top. Representative of 3 experiments. C. Electron microscopy was
used in order to characterize Aß1–42 fibrils. Negative staining using
uranyl acetate undoubtedly showed the presence of large fibrils in
solution. Most fibrils were similar in width and with a length that
Ab and Mitochondrial Ca
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Representative of 6 experiments. Ab1–42 oligomers and fibrils were
also characterized by amino acid analysis for testing actual
concentration values and composition (data not shown).
Found at: doi:10.1371/journal.pone.0002718.s001 (9.36 MB TIF)
Figure S2 Ab25-35 induces apoptosis and cell death in
cerebellar granule cells. A. Cerebellar granule cells were
cultured for 72 h in vehicle (control) or Ab25–35 (20 mM) and
apoptosis was tested by TUNEL assay. Pictures show nuclei (blue)
and apoptotic cells (purple). Bars show % of apoptotic cells (n=3;
*p,0,05). Scale bar represents 10 mm. B. Cerebellar granule cells
were cultured for 72 h with vehicle (control) or Ab25–35 (20 mM)
and cell death was assessed by staining with FDA (green, living
cells) and PI (red, dead cells). Bars show % of dead cells (n=3;
*p,00 5vs. control). Scale bar represents 10 mm.
Found at: doi:10.1371/journal.pone.0002718.s002 (6.71 MB TIF)
Figure S3 FCCP prevents the mitochondrial (but not the
cytosolic) Ca
2+ rise and cytochrome c release induced by
Ab25–35. A. Cerebellar granule cells expressing mGA were
subjected to bioluminescence for [Ca
2+]mit measurements. FCCP
100 nM inhibits the increase in [Ca
2+]mit induced by Ab25–35
(20 mM, 17 cells, 3 experiments). After washout of FCCP, Ab25–35
was able to increase [Ca
2+]mit. B. Cerebellar granule cells were
loaded with fura2/AM and subjected to fluorescence imaging for
[Ca
2+]cyt measurements. FCCP 100 nM failed to inhibit the
increase in [Ca
2+]cyt induced by Ab25–35 (20 mM) (n=273 cells, 3
experiments). C. Immunofluorescence against cytochrome c was
assessed by confocal microscopy in cerebellar granule cells treated
with vehicle (Control), Ab25–35 20 mM( A b) and 20 mMA b25–35 +
FCCP 100 nM (Ab+FCCP) for 72 h. Ab25–35 promotes diffusion
of cytochrome c that normally shows a punctate staining reflecting
mitochondrial location. 100 nM FCCP prevented diffusion of
cytochrome C. Scale bar represents 10 mm. D. Bars show % of
cells showing diffuse staining for cytochrome c (reflecting
cytochrome c release). Ab25–35 (20 mM) increases the percent of
cells showing diffuse staining an this effect was inhibited by FCCP
100 nM.
ap,0,05 vs. control;
bp,0,05 vs. Ab treated cells. Bars
are mean6SEM of 3 independent experiments.
Found at: doi:10.1371/journal.pone.0002718.s003 (2.27 MB TIF)
Figure S4 Ab oligomers induce ROS formation that is
prevented by FCCP and R-flurbiprofen. Cerebellar granule
cells were incubated for 4 h with vehicle, Ab1–42 oligomers (500
nM) and oligomers plus FCCP 100 nM or R-flurbiprofen. Then,
ROS production was imaged using the ROS-sensitive probe CM-
H2DCFDA. Ab1–42 oligomers induced an increase in fluorescence
compared to the vehicle that was prevented by FCCP and R-
flurbiprofen. The Pictures are representative of 5–9 microscopic
fields in at least 3 independent experiments for each condition.
Addition of FCCP or R-flurbiprofen alone produced similar results
than vehicle (data not shown).
Found at: doi:10.1371/journal.pone.0002718.s004 (2.83 MB TIF)
Figure S5 NSAIDs prevent cytochrome c release and cell
death induced by Ab25–35. A. Cerebellar granule cells were
treated with Ab25–35 (20 mM) for 72 h with or without 1 mMR -
flurbiprofen or 100 mM salicylate and fixed for analysis of
cytochrome c location using confocal microscopy. Control cells
showed a punctate distribution of cytochrome c. Scale bar
represents 10 mm. Ab25–35 treated cells show a more diffuse
pattern of cytochrome c whereas cells treated with Ab25–35 and R-
flurbiprofen show a punctate pattern similar to control cells. Bars
show the relative abundance (%) of cells showing diffuse
immunostaining in control cells, cells treated with Ab25–35 and
cells treated with Ab25–35 plus 1 mM R-flurbiprofen (B) or 100 mM
salicylate (C). (*p,0,05 vs. control; #p,0,05 vs. Ab). D. Effects of
ibuprofen (Ibu), indomethacin (Indo) and sulindac sulfide (Sul), all
tested at 1 mM, on cell death induced by Ab25–35 (20 mM) as
assessed by dye exclusion studies. E. Effects of R- and S-
flurbiprofen (Rf and Sf), both tested at 1 mM, on cell death
induced by Ab25–35.* p ,0,05 vs. control;
#p,0,05 vs. Ab. All
data are representative of 3 experiments.
Found at: doi:10.1371/journal.pone.0002718.s005 (2.10 MB TIF)
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